Results 271 to 280 of about 58,087 (312)

[The lacrimal apparatus as an organ at risk during radionuclide therapy]. [PDF]

Probl Endokrinol (Mosk)
Sheremeta MS, Trukhin AA, Yartsev VD, Yudakov DV, Korchagina MO, Gojaeva SA.   +5 more
europepmc   +1 more source

Peptide receptor radionuclide therapy for ectopic Cushing's syndrome caused by metastatic neuroendocrine neoplasms. [PDF]

Endocr Oncol
Boehm E, Hung T, Akhurst T, Alipour R, Chiang C, Hicks RJ, Hofman MS, Ravi Kumar AS, Sachithanandan N, Saghebi J, Michael M, Kong G.   +11 more
europepmc   +1 more source

Peptide Receptor Radionuclide Therapy and clinical associations with renal and hematological toxicities and survival in patients with neuroendocrine tumors: an analysis from two U.S. medical centers. [PDF]

J Cancer Res Clin Oncol
Xu T, Dillon JS, Maluccio MA, Quelle DE, Nash SH, Cho H, Limbach KE, Skill NJ, Bren-Mattison Y, O'Rorke MA.   +9 more
europepmc   +1 more source

Correction to: Dual Radionuclide Therapy: The Synergistic Effects of [¹⁶¹Tb]Tb-PSMA and [¹⁷⁷Lu]Lu-PSMA in Advanced Prostate Cancer Post [¹⁷⁷Lu]Lu-PSMA Failure. [PDF]

Nucl Med Mol Imaging
Abdlkadir AS, Abufara A, Al-Ibraheem A.
europepmc   +1 more source

Cutaneous Neuroendocrine Metastases of Visceral Origin Responsive to Surgical Resection and Targeted Radionuclide Therapy. [PDF]

Case Rep Dermatol Med
Tung-Hahn E, El-Haddad G, Strosberg J.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Radionuclide Therapy

Clinical Oncology, 1999
Nuclear medicine therapy uses unsealed radioactive sources for the selective delivery of radiation to tumours or target organs. For benign disorders such as thyrotoxicosis and arthritis radionuclide therapy provides an alternative to surgery or medical treatment.
R B, Buchanan, V J, Lewington
openaire   +5 more sources

Radionuclides in Therapy

American Journal of Clinical Oncology, 1989
This book presents a survey of uses of parenterally administered radionuclides as therapeutic sources and concentrates on both the basic considerations of each mode of use as well as the clinical results and experiences. This volume provides a source of information for the clinical physician and scientist involved in therapy, and describes current ...
R.P. Spencer, R.H. Seevers, A.M. Friedman   +2 more
openaire   +2 more sources

Radionuclide Therapy and Immunomodulation

2021
External beam radiation therapy (EBRT) stands as one of the pillars of cancer treatment around the world and has been widely used for decades as a curative and palliative therapy. For most of that time, the prevailing explanation for its antitumor effect has been the induction of complex DNA damage leading to cell death.
Rachel Anderson, Katherine A. Vallis
openaire   +2 more sources

Radionuclides and therapy of thyroid cancer

Nuclear Medicine Communications, 1993
The majority of thyroid carcinomas are removed surgically. The appropriate surgical technique is still debated. After surgery the amount of residual thyroid or tumour and the presence of local or distant metastases is often in doubt, particularly if it is not detectable clinically. Therefore, methods for determining the presence of disease or the later
O'Doherty, M J, Nunan, T O, Croft, D N
openaire   +3 more sources